FIL Ltd cut its position in Stryker Corporation (NYSE:SYK) by 5.4% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 136,507 shares of the medical technology company’s stock after selling 7,790 shares during the quarter. FIL Ltd’s holdings in Stryker Corporation were worth $18,944,000 at the end of the most recent reporting period.

Other large investors have also recently bought and sold shares of the company. Vanguard Group Inc. grew its position in Stryker Corporation by 2.8% in the 2nd quarter. Vanguard Group Inc. now owns 24,078,709 shares of the medical technology company’s stock worth $3,341,643,000 after purchasing an additional 657,656 shares during the last quarter. BlackRock Inc. grew its position in Stryker Corporation by 5.2% in the 2nd quarter. BlackRock Inc. now owns 23,115,853 shares of the medical technology company’s stock worth $3,208,017,000 after purchasing an additional 1,139,082 shares during the last quarter. Fundsmith LLP grew its position in Stryker Corporation by 4.6% in the 1st quarter. Fundsmith LLP now owns 5,175,453 shares of the medical technology company’s stock worth $681,348,000 after purchasing an additional 226,057 shares during the last quarter. Wellington Management Group LLP grew its position in Stryker Corporation by 0.5% in the 1st quarter. Wellington Management Group LLP now owns 4,569,118 shares of the medical technology company’s stock worth $601,525,000 after purchasing an additional 24,139 shares during the last quarter. Finally, Geode Capital Management LLC grew its position in Stryker Corporation by 6.3% in the 1st quarter. Geode Capital Management LLC now owns 2,786,406 shares of the medical technology company’s stock worth $366,255,000 after purchasing an additional 166,133 shares during the last quarter. Institutional investors and hedge funds own 74.13% of the company’s stock.

Several research firms have issued reports on SYK. SunTrust Banks, Inc. restated a “buy” rating and issued a $161.00 price target on shares of Stryker Corporation in a research report on Monday, October 2nd. Royal Bank Of Canada restated a “buy” rating and issued a $155.00 price target on shares of Stryker Corporation in a research report on Monday, October 2nd. BidaskClub upgraded shares of Stryker Corporation from a “hold” rating to a “buy” rating in a research report on Thursday, August 17th. Cowen and Company restated a “buy” rating and issued a $160.00 price target (up from $150.00) on shares of Stryker Corporation in a research report on Sunday, July 30th. Finally, Zacks Investment Research lowered shares of Stryker Corporation from a “buy” rating to a “hold” rating in a research report on Wednesday, August 23rd. Two research analysts have rated the stock with a sell rating, nine have given a hold rating and twelve have issued a buy rating to the stock. The stock has a consensus rating of “Hold” and an average target price of $146.78.

Stryker Corporation (SYK) opened at 146.56 on Friday. The company has a market capitalization of $54.82 billion, a P/E ratio of 32.71 and a beta of 0.80. Stryker Corporation has a 12-month low of $106.48 and a 12-month high of $149.23. The stock’s 50 day moving average is $142.74 and its 200-day moving average is $140.38.

Stryker Corporation (NYSE:SYK) last released its quarterly earnings results on Thursday, July 27th. The medical technology company reported $1.53 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $1.51 by $0.02. Stryker Corporation had a net margin of 14.22% and a return on equity of 24.26%. The business had revenue of $3.01 billion for the quarter, compared to the consensus estimate of $2.98 billion. During the same period in the prior year, the company posted $1.39 earnings per share. Stryker Corporation’s revenue was up 6.1% compared to the same quarter last year. On average, equities analysts predict that Stryker Corporation will post $6.45 earnings per share for the current fiscal year.

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, October 31st. Investors of record on Friday, September 29th will be paid a $0.425 dividend. The ex-dividend date is Thursday, September 28th. This represents a $1.70 annualized dividend and a dividend yield of 1.16%. Stryker Corporation’s dividend payout ratio (DPR) is presently 37.95%.

In related news, insider Lonny J. Carpenter sold 5,000 shares of the company’s stock in a transaction dated Friday, August 4th. The shares were sold at an average price of $146.36, for a total transaction of $731,800.00. Following the completion of the sale, the insider now owns 88,207 shares of the company’s stock, valued at $12,909,976.52. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Graham A. Mclean sold 1,124 shares of the company’s stock in a transaction dated Tuesday, August 8th. The stock was sold at an average price of $146.26, for a total transaction of $164,396.24. Following the sale, the insider now directly owns 8,983 shares of the company’s stock, valued at approximately $1,313,853.58. The disclosure for this sale can be found here. Corporate insiders own 7.40% of the company’s stock.

TRADEMARK VIOLATION NOTICE: “Stryker Corporation (SYK) Shares Sold by FIL Ltd” was first posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this report on another site, it was stolen and reposted in violation of US & international copyright law. The legal version of this report can be accessed at https://www.thecerbatgem.com/2017/10/13/stryker-corporation-syk-shares-sold-by-fil-ltd.html.

Stryker Corporation Profile

Stryker Corporation is a medical technology company. The Company offers a range of medical technologies, including orthopedic, medical and surgical, and neurotechnology and spine products. The Company’s segments include Orthopaedics; MedSurg; Neurotechnology and Spine, and Corporate and Other. The Orthopaedics segment includes reconstructive (hip and knee) and trauma implant systems and other related products.

Institutional Ownership by Quarter for Stryker Corporation (NYSE:SYK)

Receive News & Stock Ratings for Stryker Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stryker Corporation and related stocks with our FREE daily email newsletter.